BCHE and Alzheimer disease: As the etiology and pathophysiology of AD are multifactorial and complex, only a few symptomatic treatments, such as cholinesterase inhibitors and memantine, are approved for AD therapy; however, no disease-modifying therapies are currently available2, 3, 4.